Document Detail
Language: English
|
|||||||
![]() Understanding risk in pharmaceutical supply chains
Risk in pharmaceuticals is often associated with drug shortages: events that prevent patients getting the right medicines at the right time. In traditional supply chains, supply risk is typically managed through increased inventory. However, excessive inventory is unsustainable, and may conceal the variety of factors that may result in supply disruption.
This briefing offers multiple lenses to focus on pharmaceutical supply chain risk:
Outputs are generated at three levels, each contributing to more informed risk mitigation:
About ReMediES The ReMediES (Reconfiguring Medicines End-to-end Supply) project - involving 22 industrial partners comprising global pharmaceutical companies, major contract manufacturing organisations, equipment manufacturers, and logistics specialists – examined future pharmaceutical supply chains supported by novel technology. |
Other Documents of
University of Cambridge - IfM in English : |
||||
|